360° SearchNetwork Hot Spots Trends Time Series

Curis Incorporated

Type: Company

Name: Curis Incorporated

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Curis Resources to raise USD 6 million for Florence project development

Curis Resources has arranged to raise USD 6 million through a non brokered private placement financing with funds to be used to advance the development of the company's Florence copper project in Arizona, which earlier this year yielded strong economics ... [Published Steel Guru - May 17 2013]

Entities: Copper, Curis Incorporated, Mining

First reported May 16 2013 - Updated May 16 2013 - 4 reports

American Society of Clinical Oncology

Curis, Inc. (CRIS) Announces Presentation of CUDC-427 and Erivedge® Clinical Results at American Society of Clinical Oncology Annual Meeting

Staying up-to-date has never been simpler. Sign up for the today! LEXINGTON, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, ... [Published BioSpace - May 16 2013]

Entities: Curis Incorporated, Erivedge, American Society of Clinical Oncology

First reported May 15 2013 - Updated May 15 2013 - 2 reports

US Environmental Protection Agency

Curis Resources puts to bed $6 mln financing for Florence project

Curis Resources ( TSE:CUV ) says it has closed the C$6 million non-brokered financing it announced earlier this week for its Florence copper project in Arizona, putting it one step closer to bringing the mine to production. The company said late ... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2013]

Entities: Copper, Curis Incorporated, US Environmental Protection Agency, Permitting, Natural Resources

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Curis Resources closes $6-million financing

Curis Resources Ltd. has completed the previously announced $6-million non-brokered private placement of 6,818,182 common shares in the capital of Curis at a price of 88 cents per share. The common shares are subject to a four-month-and-a-day hold period. ... [Published Stockwatch - May 15 2013]

Entities: Private Placement, Common Shares, Curis Incorporated

First reported May 14 2013 - Updated May 15 2013 - 2 reports

Curis Closes CAD $6 Million Private Placement Financing CNW Group

/CNW/ - Curis Resources Ltd. ("Curis" or the "Company") (CUV.TO) announces that it has completed the previously announced CAD $6 million non-brokered private placement of 6,818,182 common shares in the capital of Curis at a price of CAD $0.88 per share. ... [Published Yahoo! Finance - May 15 2013]

Entities: Curis Incorporated, CNW Group, Private Placement

First reported May 14 2013 - Updated May 14 2013 - 1 reports

WellPoint Inc

Three of WellPoint's directors resign for personal reasons

May 13 (Reuters) - Health insurer WellPoint Inc said three of its directors resigned, effective immediately, citing personal reasons.WellPoint said in a regulatory filing on Monday that it received notice of resignations from Lenox Baker Jr., Susan Bayh ... [Published Reuters - May 14 2013]

Entities: WellPoint Inc, Resignation, Susan Bayh, Lenox Baker, Sheila Burke

First reported May 13 2013 - Updated May 13 2013 - 5 reports

Curis Resources to raise $6 mln for Florence project development

Curis Resources ( TSE:CUV ) has arranged to raise $6 million through a non-brokered private placement financing, with funds to be used to advance the development of the company's Florence copper project in Arizona, which earlier this year yielded ... [Published Proactiveinvestors United Kingdom RSS feed - May 13 2013]

Entities: Curis Incorporated, Copper, Natural Resources, Mining, Thomas Lau

First reported May 13 2013 - Updated May 13 2013 - 2 reports

Curis announces approval of Erivedge anticancer drug in Australia

Home » Syndicated Content » Curis announces approval of Erivedge anti-cancer drug in AustraliaOncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with ... [Published BioPortfolio - May 13 2013]

Entities: Erivedge, Curis Incorporated, Australia, antineoplastic, Drugs

First reported May 10 2013 - Updated May 10 2013 - 3 reports

Curis, Inc. Announces Approval of Erivedge® in Australia

(GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced that ErivedgeÂ® (vismodegib) was approved for marketing registration by Australia's ... [Published BioSpace - May 10 2013]

Entities: Erivedge, Curis Incorporated, basal cell carcinoma, Australia

First reported Apr 29 2013 - Updated Apr 30 2013 - 2 reports

EU committee recommends conditional approval of Rocheâs Erivedge for advanced basal cell carcinoma

The European Union’s Committee for Medicinal Products for Human Use (CHMP) has recommended conditional approval of Roche's Erivedge (vismodegib) for the treatment of adult patients with symptomatic metastatic basal cell carcinoma, or locally advanced ... [Published PharmaBiz - Apr 30 2013]

Entities: Erivedge, basal cell carcinoma, Roche Holding AG, Patient

First reported Apr 23 2013 - Updated Apr 23 2013 - 2 reports

Curis to Release First Quarter 2013 Financial Results and Hold Conference Call on April 30, 2013

CONTACT: Michael P. GrayChief Financial OfficerCuris, Inc.617-503-6632mgray@curis.com ... [Published Reuters - Apr 23 2013]

Entities: Curis Incorporated

First reported Apr 19 2013 - Updated Apr 19 2013 - 6 reports

Curis Resources Says Lawsuit Challenging Operational Permit For Florence Project Dismissed

Curis Resources ( TSE:CUV ) says that a lawsuit against the company that challenged the validity of regulations governing certain permits for its Florence copper project in Arizona has been dismissed.The lawsuit, which was filed against the Arizona Department ... [Published Seeking Alpha - Apr 19 2013]

Entities: Curis Incorporated, Copper, Lawsuit

Quotes

Mr Michael McPhie president and CEO of Curis Resources said that "The financing has been arranged at a premium to current market prices at a time when many companies in the mining industry are having significant challenges raising capital. This investment is a strong indication of support and confidence in the management and future prospects of Curis and our flagship Florence Copper project."

Curis Resources to raise USD 6 million for Florence project development [Published Steel Guru - May 17 2013]

"Each of the named directors resigned for personal reasons and there were no disagreements or disputes between the company and any of the named directors which led to their resignation" the second-largest U S health insurer said

Three of WellPoint's directors resign for personal reasons [Published Reuters - May 14 2013]

...matches our fund's investment strategy in Canada's natural resources sector," said managing partner of Sino-Canada Natural Resources, Thomas Lau. "The Sino-Canada Natural Resources Fund will keep supporting Curis to reach commercial production in the near term."

Curis Resources to raise $6 mln for Florence project development [Published Proactiveinvestors United Kingdom RSS feed - May 13 2013]

...many companies in the mining industry are having significant challenges raising capital," commented Michael McPhie, President and CEO of Curis. "This investment is a strong indication of support and confidence in the management and future prospects of Curis and our flagship Florence Copper project. The funding provides Curis with additional resources to advance Florence Copper through the final stage of project permitting for our first phase of development as well as working capital to support the ongoing growth and development of the Company."

Curis Resources arranges $6-million private placement [Published Stockwatch - May 13 2013]

More Content

sort by: Date \| Relevance
Curis Resources to raise USD 6 million for Flor... [Published Steel Guru - May 17 2013]
Reminder Remembers 5/16/13 [Published TriValleyCentral.com - May 17 2013]
Curis, Inc. (CRIS) Announces Presentation of CU... [Published BioSpace - May 16 2013]
Curis Announces Presentation of CUDC-427 and Er... [Published Reuters - May 16 2013]
Curis Announces Presentation of CUDC-427 and Er... [Published Morningstar.com - May 16 2013]
Curis Announces Presentation of CUDC-427 and Er... [Published Nasdaq - May 16 2013]
Curis Resources puts to bed $6 mln financing fo... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2013]
Curis Resources puts to bed $6 mln financing fo... [Published Proactive Investors USA - May 15 2013]
Curis Resources closes $6-million financing [Published Stockwatch - May 15 2013]
Curis Closes CAD $6 Million Private Placement F... [Published Yahoo! Finance - May 15 2013]
Curis Closes CAD $6 Million Private Placement F... [Published Canada NewsWire - May 14 2013]
Three of WellPoint's directors resign for perso... [Published Reuters - May 14 2013]
Curis Resources to raise $6 mln for Florence pr... [Published Proactiveinvestors United Kingdom RSS feed - May 13 2013]
Curis Resources to raise $6 mln for Florence pr... [Published Proactive Investors USA - May 13 2013]
Curis Resources arranges $6-million private pla... [Published Stockwatch - May 13 2013]
Curis announces approval of Erivedge anticancer... [Published BioPortfolio - May 13 2013]
Curis Resources Ltd Announces $6 Million Privat... [Published Reuters - May 13 2013]
Curis announces approval of Erivedge anti-cance... [Published PBR - News - May 13 2013]
Curis announces $6 million private placement fi... [Published Canada NewsWire - May 13 2013]
Curis, Inc. Announces Approval of Erivedge® in ... [Published BioSpace - May 10 2013]
Swiss Stocks Extend Five-Year High as SMI Gains... [Published La Repubblica - May 10 2013]
Pre-market Movers For May 10 (DELL, PGNX, CRIS,... [Published RTTNews.com - May 10 2013]
CURIS, INC.: Curis Announces Approval of Erived... [Published 4 Traders - May 10 2013]
Curis Announces Approval of Erivedge(R) in Aust... [Published Reuters - May 10 2013]
Curis Announces Approval of Erivedge(R) in Aust... [Published GlobeNewswire - May 10 2013]
Curis, Inc. (CRIS) - Financial and Strategic SW... [Published TransWorldNews - May 10 2013]
Mother's Day is a Couture Family Affair for She... [Published Shelby-Utica Patch - May 10 2013]
Curis says town misrepresents them once again [Published TriValleyCentral.com - May 09 2013]
Form 4 CURIS INC For: May 06 Filed by: TOBIN JA... [Published Street Insider - May 07 2013]
Form 4 CURIS INC For: May 02 Filed by: PASSERI ... [Published Street Insider - May 06 2013]

Blogs

sort by: Date \| Relevance
Curis announces approval of Erivedge anti-cance... [Published PBR - News - May 13 2013] Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for surgery and/or ...
Curis Earnings: Here’s Why Investors Don’t Like... [Published Wall St. Cheat Sheet - Apr 30 2013] Curis Inc. ( NASDAQ:CRIS ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 2.98%. Markets ...
EMA announces positive CHMP opinion for conditi... [Published PBR - News - Apr 29 2013] The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has announced positive opinion for conditional approval of Curis' Erivedge in European Union. ...
Curis Resources says lawsuit challenging operat... [Published Proactiveinvestors United Kingdom website - Apr 19 2013] Curis Resources ( TSE:CUV ) says that a lawsuit against the company that challenged the validity of regulations governing certain permits for its Florence copper project in Arizona has been dismissed. The lawsuit, which was filed against the Arizona ...
Analysts: Salesforce is a Buy and 4 Stocks With... [Published Wall St. Cheat Sheet - Mar 01 2013] Salesforce.com ( NYSE:CRM ): Current Price: $174.32 The company’s price target has been raised by Roth Capital after reporting stronger Q4 results than expected. The firm keeps its Buy rating on the stock. Baird cited Salesforce.com’s organic growth ...

Press Releases

sort by: Date \| Relevance
Curis Reports First Quarter 2013 Financial Results [Published GlobeNewswire: Advertising News - Apr 30 2013]
Curis Announces Erivedge(R) Receives Positive C... [Published GlobeNewswire: Acquisitions News - Apr 26 2013]
Curis to Release First Quarter 2013 Financial R... [Published GlobeNewswire: Acquisitions News - Apr 23 2013]
Curis to Present at the BioCentury Future Leade... [Published GlobeNewswire: Advertising News - Mar 29 2013]
Curis to Present at the Roth Capital Partners 2... [Published GlobeNewswire: Advertising News - Mar 11 2013]